Merk reported $10.97B in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US USD 8.64B 245M
Abbvie ABBV:US USD 10.21B 1.08B
ALKERMES ALKS:US USD 313M 2.32M
Amgen AMGN:US USD 3.91B 504M
Astrazeneca AZN:US USD 9.74B 495M
AstraZeneca AZN:LN USD 9.74B 495M
Biogen BIIB:US USD 1.19B 1.45B
Bristol Myers Squibb BMY:US USD 8.75B 552M
Catalent CTLT:US USD 962M 105M
Coherus Biosciences CHRS:US USD 125.87M 21.71M
Eli Lilly And LLY:US USD 5.27B 12.8M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Glaxosmithkline GSK:US GBP 6.64B 790M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
JAZZ PHA JAZZ:US USD 915.89M 68.56M
Johnson & Johnson JNJ:US USD 17.97B 211M
Medtronic MDT:US USD 6.18B 125M
Merk MRK:US USD 10.97B 1.31B
Novartis NOVN:VX USD 10.67B 183M
Novartis NVS:US USD 10.67B 183M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 13.23B 2.41B
Prestige Brands PBH:US USD 204.89M 14.84M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Revance Therapeutics RVNC:US USD 106.5M 20.29M
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B
United Therapeutics UTHR:US USD 201.7M 63.4M
Zoetis ZTS:US USD 1.34B 47M